Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

DexCom, Inc. (DXCM) Price to free cash flow

As of 25 September 2026, DexCom, Inc. (DXCM) trades at a price to free cash flow of 23.6×. Over the past ten years it has ranged from 0.0× (December 2017) to 14,292× (January 2017); the current reading is higher than 19% of that period. That is in line with the Medical Devices industry median of 22.5× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 24.0× (50.46%)
FY2024 48.5× (47.71%)
FY2023 92.8× (36.70%)
FY2022 147× 667.76%
FY2021 19.1× (84.86%)
FY2020 126× (14.86%)
FY2019 148× (21.33%)
FY2018 188× (2.16%)
FY2017 193× (98.02%)
FY2016 9,738× 2,238.65%

Quarterly

Period Price to free cash flow Change
Jun 2026 18.3× 8.29%
Mar 2026 16.9× (29.63%)
Dec 2025 24.0× (2.99%)
Sep 2025 24.8× (58.67%)
42 more quarters

Against its own ten years

Low 0.0× High 14,292×
Ten-year median 143×
Current reading's percentile 19

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 6.0×
PHG Koninklijke Philips N.V. compare 12.9×
ZBH Zimmer Biomet Holdings, Inc. compare 16.9×
BSX Boston Scientific Corporation compare 17.8×
GEHC GE HealthCare Technologies Inc. compare 19.1×
STE STERIS plc compare 21.8×
DXCM DexCom, Inc. 23.6×
EW Edwards Lifesciences Corporation compare 35.4×
PEN Penumbra, Inc. compare 58.1×
Medical Devices industry median 22.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on DXCM